Rachel M. Black
MANAGER, VALUE EVIDENCE
Iota is commonly thought of as a very small amount. In physics, it can be used to represent intensity. Even a small unit of power, when constantly supplied, can result in a force to be reckoned with. In my experience, success is achieved through a conglomeration of small acts of hard work done continuously with diligence. The collective work of the dedicated and talented team at AESARA results in an intensity that is unmatched.
Rachel Black is a Manager in the Value Evidence. Previously, Rachel was the inaugural Market Access and Informatics Fellow with AESARA and the University of North Carolina (UNC) Eshelman School of Pharmacy. During her fellowship she performed health outcomes research with faculty in the Divisions of Pharmaceutical Outcomes and Policy (DPOP) and Practice Advancement and Clinical Education (PACE).
At AESARA, Rachel has collaborated with pharmaceutical clients on US and global market access and reimbursement strategy and contributed to HEOR projects including database claims analyses and AMCP dossier writing. She has developed unique and creative communication pieces to highlight product value to payers and conducted targeted competitive research to guide evidence generation strategy.
Rachel holds a Doctor of Pharmacy (PharmD) from UNC. During pharmacy school, she served as a leader of UNC’s Academy of Managed Care Pharmacy (AMCP) chapter and a member of Rho Chi, the National Pharmacy Academic Honors Society. She also held internships at GlaxoSmithKline (GSK) and IQVIA.
During her time as an undergraduate, she obtained a Bachelor of Science in Biology and played on the two-time ACC Champion UNC Field Hockey team.
- Black RM, Freifeld C, Hogue S, DeCoteau S, Pham S. Leveraging Social Media for Patient Experience Insights in Rare Disease. Poster presented at ISPOR; May 15-18, 2022; Washington DC
- Black RM, Stanford RS, Gratie D. The Burden of Illness Associated with Recurrent Clostridioides difficile Infection: A Claims-based Analysis. Poster presented at ID Week 2021; September 29-October 3, 2021; Virtual.
- Black RM, Williams AK, Ratner L, et al. Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients. Pharmacogenomics. 2020;21(7):431‐441.
Areas of Expertise
- Health outcomes research
- Pharmacogenomics research
AESARA Scholar Program
AESARA/UNC Market Access and Health Informatics Fellow – Class 2022
- MPS, Biomedical and Health Informatics, University of North Carolina at Chapel Hill (ongoing)
- Post-doctoral fellowship, Market Access and Informatics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC
- PharmD, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC
- BS, Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC